Differential expression of acidic and basic fibroblast growth factors in benign prostatic hyperplasia identified by immunohistochemistry

British Journal of Urology

Volumn 80, Issue 6, 1997, Pages 869-874

  Deshmukh, N ^a   Scotson, J ^a   Dodson, A R ^a   Smith, P H ^a   Ke, Y ^a   Foster, C S ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Autocrine paracrine modulation; Benign prostatic hyperplasia; Differential expression; Fibroblast growth factors; Immunohistochemistry

Indexed keywords

ACIDIC FIBROBLAST GROWTH FACTOR; ANTIBODY; BASIC FIBROBLAST GROWTH FACTOR;

ARTICLE; CLINICAL ARTICLE; CYTOPLASM; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; STAINING;

EID: 0031400524     PISSN: 00071331     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410x.1997.00479.x     Document Type: Article

References (33)

1. Jonler M, Riehmann M, Brinkmann R, Bruskewitz RC. Benign prostatic hyperplasia. Endocrinol Metab Clin North Am 1994; 23: 795-807
2. Appell RA. Pathogenesis and medical management of benign prostatic hyperplasia. Sem Neph 1994; 14: 531-43
3. McNeal JE. Normal histology of the prostate. Am J Surg Pathol 1988; 12: 619-33
4. Steiner MS. Role of peptide growth factors in the prostate - a Review. Urology 1993; 42: 99-110
5. Aumuller G, Groos S, Renneberg H, Konrad L, Aumuller M. Benign prostatic hyperplasia. In Foster C, Bostwick D eds, Pathology of the Prostate, vol 35, Philadelphia: WB Saunders, 1997: 159
6. Ehara H, Koji T, Deguchi T et al. Expression of estrogen receptor in diseased human prostate assessed by non-radioactive in situ hybridization and immunohistochemistry. Prostate 1995; 27: 304-13
7. Srinivasan G, Campbell E. Bashirelahi N. Androgen, estrogen and progesterone receptors in normal and aging prostates. Micros Res Tech 1995; 30: 293-304
8. Farnsworth WE. TRH: mediator of prolactin in the prostate? Med Hypoth 1993; 41: 450-4
9. Sinowatz F, Amselgruber W, Plendl J, Kolle S, Neumuller C, Boos G. Effects of hormones on the prostate in adult and aging men and animals. Micros Res Tech 1995; 30: 282-92
10. Schweikert HU, Tunn UW, Habenicht UF et al. Effects of estrogen deprivation on human benign prostatic hyperplasia. J Steroid Biochem Mol Biol 1993; 44: 573-6
11. Story MT, Hopp KA, Molter M, Meier DA. Characteristics of FGF-receptors expressed by stromal and epithelial cells cultured from normal and hyperplastic prostates. Growth Factors 1994; 10: 269-80
12. Nakamoto T, Chang CS, Li AK, Chodak GW. Basic fibroblast growth factor in human prostate cancer cells. Cancer Res 1992; 52: 571-7
13. Cunha GR, Alarid ET, Turner T, Donjacour AA, Boutin EL, Foster BA. Normal and abnormal development of the male urogenital tract. Role of androgens, mesenchymal-epithelial interactions and growth factors. J Androl 1992; 13: 465-75
14. Gleason PE, Jones EA, Regan JS et al. Platelet derived growth factor (PDGF), androgens and inflammation: possible etiologic factors in the development of prostatic hyperplasia. J Urol 1993; 149: 1586-92
15. Harper ME, Goddard L, Glynne-Jones E et al. An immunocytochemical analysis of TGF-alpha expression in benign and malignant prostatic tumors. Prostate 1993; 23: 9-23
16. Yang Y, Chisholm GD, Habib FK. Epidermal growth factor and transforming growth factor alpha concentrations in BPH and cancer of the prostate: their relationships with tissue androgen levels. Br J Cancer 1993; 67: 152-5
17. Jones EG, Harper ME. Studies on the proliferation, secretory activities and epidermal growth factor receptor expression in benign prostatic hyperplasia explant cultures. Prostate 1992; 20: 133-49
18. Story MT, Hopp KA, Meier DA, Begun FP, Lawson RK. Influence of transforming growth factor beta 1 and other growth factors on basic fibroblast growth factor, level and proliferation of cultured human prostate-derived fibroblasts. Prostate 1993; 22: 183-97
19. Steiner MS. Review of peptide growth factors in benign prostatic hyperplasia and urological malignancy. J Urol 1995; 153: 1085-96
20. Begun FP, Story MT, Hopp KA, Shapiro E, Lawson RK. Regional concentration of basic fibroblast growth factors in normal and benign hyperplastic human prostates. J Urol 1995; 153: 839-43
21. Pusztai L, Lewis CE, Lorenzen J, McGee JOD. Growth factors: regulation of normal and neoplastic growth. J Pathol 1993; 169: 191-201
22. Helpap B. Benign prostatic hyperplasia. In Foster C, Bostwick D eds, Pathology of the Prostate. Vol 35, Philadelphia: WB Saunders, 1997:??
23. Jacobs SC, Story MT, Sasse J, Lawson RK. Characterisation of growth factors derived from the rat ventral prostate. J Urol 1988; 139: 1106-10
24. Nishi N, Matuo Y, Kunitimo K et al. Comparative analysis of growth factors in normal and pathologic human prostates. Prostate 1988; 13: 39-48
25. Mydlo JH, Bulbul MA, Richon VM, Huston WDW, Fair WR. Heparin binding growth factor isolated from human prostatic extracts. Prostate 1988; 12: 343-55
26. Payson RA, Canatan H, Chotani MA et al. Cloning of two novel forms of human acidic fibroblast growth factor (aFGF) mRNA. Nucl Acids Res 1993; 21: 489-95
27. Mansson PE, Adams P, Kan M, McKeehan WL. Heparin-binding growth factor gene expression and receptor characteristics in normal rat prostate and two transplantable rat prostate tumors. Cancer Res 1989; 49: 2485-94
28. Sherwood ER, Fong CJ, Lee C, Kozlowski JM. Basic fibroblast growth factor. A potential mediator of stromal growth in the human prostate. Endocrinology 1992; 130: 2955-63
29. Gospodarowicz D, Ferrara N, Schweigerer L, Neufeld G. Structural characterisation and biological functions of fibroblast growth factor. End Rev 1987; 8: 95-114
30. Robert M, Costa P, Bressolle F, Mottet N, Navratil H. Percentage area density of epithelial and mesenchymal components in benign prostatic hyperplasia: comparison of results between single biopsy, multiple biopsies and multiple tissue specimens. Br J Urol 1995; 75: 317-24
31. Cohen P, Peehl DM, Baker B, Liu F, Hintz RL, Rosenfeld RG. Insulin-like growth factor axis abnormalities in prostatic stromal cells from patients with benign prostatic hyperplasia. J Clin End Metab 1994; 79: 1410-5
32. Geller J, Sionit LR, Baird A, Kohls M, Conners KM, Hoffman RM. In vivo and in vitro effects of androgen on fibroblast growth factor-2 concentrations in the human prostate. Prostate 1994; 25: 206-9
33. Mydlo JH, Michaeli J, Heston WDW, Fair WR. Expression of basic fibroblast growth factor mRNA in benign prostatic hyperplasia and prostatic carcinoma. Prostate 1988; 13: 241-7